Zde se nacházíte:
Informace o publikaci
Clinical Outcomes of Patients with Nonseminomatous Germ Cell Tumours and Negative Postchemotherapy Positron Emission Tomography
| Autoři | |
|---|---|
| Rok publikování | 2012 |
| Druh | Článek v odborném periodiku |
| Časopis / Zdroj | Cancer Investigation |
| Fakulta / Pracoviště MU | |
| Citace | |
| Doi | https://doi.org/10.3109/07357907.2012.679347 |
| Obor | Onkologie a hematologie |
| Klíčová slova | Positron emission tomography; Germ cell tumour; Testicular cancer; Diagnosis; Relapse |
| Přiložené soubory | |
| Popis | Univariate and multivariate analyses were carried out to identify factors associated with the failure of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) to correctly predict relapse-free survival in patients with nonseminomatous germ cell tumours. Ninety-three patients with negative postchemotherapy FDG-PET scan were analyzed in the retrospective study. The FDG-PET result was validated by long-term follow-up and, in some patients, by resection of the residual tumour mass. The negative predictive value of FDG-PET was 81.7%. Higher tumour marker levels and nodal stage at diagnosis, presence of residual mass, and teratoma or teratocarcinoma in the primary histology were associated with FDG-PET failure. |